Acta Ophthalmol

1. SU ZZS, Ang BCH, Balne PK, Tun SBB, et al
   Effect of anti-VEGF on retinal blood flow in diabetic mice using laser speckle flowgraphy.
   Acta Ophthalmol. 2024 Apr 4. doi: 10.1111/aos.16672.
   

   >> Share

   
   

   
   Am J Clin Nutr

2. SASSANO M, Castagna C, Villani L, Quaranta G, et al
   National taxation on sugar-sweetened beverages and its association with overweight, obesity, and diabetes.
   Am J Clin Nutr. 2024;119:990-1006.
   

   >> Share

   
   
3. BATIS C
   Taxes to sugar-sweetened beverages: are changes in obesity and diabetes observable?
   Am J Clin Nutr. 2024;119:874-875.
   

   >> Share

   
   
4. LI LJ, Lu R, Rawal S, Birukov A, et al
   Maternal Plasma Phospholipid Polyunsaturated Fatty Acids in Early Pregnancy and Thyroid Function throughout Pregnancy: A Longitudinal Study.
   Am J Clin Nutr. 2024 Feb 24:S0002-9165(24)00162.
   

   >> Share

   
   
5. AL-JAFAR R, Pinto RC, Elliott P, Tsilidis KK, et al
   Metabolomics of Ramadan fasting and associated risk of chronic diseases.
   Am J Clin Nutr. 2024;119:1007-1014.
   

   >> Share

   
   

   
   Am J Kidney Dis

6. RASARATNAM N, Salim A, Blackberry I, Cooper ME, et al
   Urine Albumin-Creatinine Ratio Variability in People With Type 2 Diabetes: Clinical and Research Implications.
   Am J Kidney Dis. 2024 Mar 15:S0272-6386(24)00620.
   

   >> Share

   
   

   
   Am J Nephrol

7. TUTTLE KR, Rossing P, Hauske SJ, Cronin L, et al
   Methods Article for a Study Protocol: Study Design and Baseline Characteristics for Aldosterone Synthase Inhibition in Chronic Kidney Disease.
   Am J Nephrol. 2024;55:262-272.
   

   >> Share

   
   

   
   Angiology

8. KARACA B, Kiris T, Ormen B, Sener A, et al
   Letter: Predictive Value of C-Reactive Protein to Albumin Ratio for Amputation Risk in Diabetic Foot Infection: Reply.
   Angiology. 2024 Apr 2:33197241245495. doi: 10.1177/00033197241245495.
   

   >> Share

   
   

   
   Ann Intern Med

9. KELSEY M, Newby LK
   In higher-risk, statin-intolerant adults with diabetes, bempedoic acid reduced MACE at a median 3 y.
   Ann Intern Med. 2024 Apr 2. doi: 10.7326/J24-0016.
   

   >> Share

   
   

   
   Atherosclerosis

10. VARGAS-VAZQUEZ A, Fermin-Martinez CA, Antonio-Villa NE, Fernandez-Chirino L, et al
    Insulin resistance potentiates the effect of remnant cholesterol on cardiovascular mortality in individuals without diabetes.
    Atherosclerosis. 2024 Mar 13:117508. doi: 10.1016/j.atherosclerosis.2024.117508.
    

    >> Share

    
    

    
    Biochem Biophys Res Commun

11. XIAN Y, Wang X, Yu Y, Chen X, et al
    Transcriptomics confirms IRF1 as a key regulator of pyroptosis in diabetic retinopathy.
    Biochem Biophys Res Commun. 2024;709:149760.
    

    >> Share

    
    
12. HUFFER A, Ozdemir T
    Substrate stiffness regulates type II diabetic fibroblast phenotype and metabolic activity.
    Biochem Biophys Res Commun. 2024;709:149833.
    

    >> Share

    
    
13. LI X, Ji Q, Zhong C, Wu C, et al
    Ghrelin regulates the endoplasmic reticulum stress signalling pathway in gestational diabetes mellitus.
    Biochem Biophys Res Commun. 2024;709:149844.
    

    >> Share

    
    

    
    BMC Ophthalmol

14. LI H, Li Z, Mao A, Dong P, et al
    A case report: co-occurrence of probable Vogt-Koyanagi-Harada disease and diabetic retinopathy.
    BMC Ophthalmol. 2024;24:148.
    

    >> Share

    
    

    
    BMC Pediatr

15. GOZUKUCUK D, Ileri BA, Baskan SK, Oztarhan E, et al
    Evaluation of cardiac autonomic dysfunctions in children with type 1 diabetes mellitus.
    BMC Pediatr. 2024;24:229.
    

    >> Share

    
    

    
    Diabet Med

16. DHATARIYA K, Lobo DN
    People with diabetes undergoing surgery: Level of knowledge of fluid prescribing in trainees in diabetes.
    Diabet Med. 2024 Mar 29:e15324. doi: 10.1111/dme.15324.
    

    >> Share

    
    
17. GIBSON R, Oliver N, McGowan B, Guess N, et al
    Developing an intervention to support dietary change for shift workers living with type 2 diabetes: A stakeholder consultation.
    Diabet Med. 2024 Mar 29:e15318. doi: 10.1111/dme.15318.
    

    >> Share

    
    
18. TROJANOWSKI PJ, Pardon A, Reynolds C, O'Donnell HK, et al
    Body mass index moderates the association between diabetes distress and objective self-management behaviours in adolescents with type 1 diabetes and elevated A1Cs.
    Diabet Med. 2024 Mar 29:e15325. doi: 10.1111/dme.15325.
    

    >> Share

    
    
19. LIND N, Christensen MB, Hansen DL, Willaing I, et al
    Peer support for adults with type 2 diabetes starting continuous glucose monitoring-An exploratory randomised controlled trial.
    Diabet Med. 2024 Apr 4:e15321. doi: 10.1111/dme.15321.
    

    >> Share

    
    
20. NEUMAN V, Piona C, Cudizio L, Drnkova L, et al
    Are we ready to screen for type 1 diabetes? A structured worldwide survey among healthcare providers involved in paediatric diabetes care.
    Diabet Med. 2024 Apr 2:e15329. doi: 10.1111/dme.15329.
    

    >> Share

    
    
21. AKYIREM S, Ekpor E, Abwoye DN, Wang K, et al
    Weight-related discrimination, perceived stress and psychological and physical well-being of persons with type 2 diabetes: A mediation analysis.
    Diabet Med. 2024 Apr 1:e15322. doi: 10.1111/dme.15322.
    

    >> Share

    
    
22. DENNISON RA, Oliver-Williams C, Qi HLJ, Kotecha D, et al
    The effectiveness of pharmacological and lifestyle interventions to reduce the risk of diabetes and hyperglycaemia following gestational diabetes: A systematic review and meta-analysis.
    Diabet Med. 2024 Mar 29:e15316. doi: 10.1111/dme.15316.
    

    >> Share

    
    

    
    Diabetes

23. RAMOS SV, Distefano G, Lui LY, Cawthon PM, et al
    Role of Cardiorespiratory Fitness and Mitochondrial Oxidative Capacity in Reduced Walk Speed of Older Adults with Diabetes.
    Diabetes. 2024 Mar 29:db230827. doi: 10.2337/db23-0827.
    

    >> Share

    
    

    
    Diabetes Care

24. DANNE T, Joubert M, Hartvig NV, Kaas A, et al
    Association Between Treatment Adherence and Continuous Glucose Monitoring Outcomes in People With Diabetes Using Smart Insulin Pens in a Real-World Setting.
    Diabetes Care. 2024 Apr 3:dc232176. doi: 10.2337/dc23-2176.
    

    >> Share

    
    
25. RIDDLE MC
    Erratum. Individualizing Treatment of Type 2 Diabetes After Metformin: More Insights From GRADE. Diabetes Care 2024;47:556-561.
    Diabetes Care. 2024 Apr 2:dc24er06a. doi: 10.2337.
    

    >> Share

    
    
26. SIMMONS D, Immanuel J, Hague WM, Teede H, et al
    Regression From Early GDM to Normal Glucose Tolerance and Adverse Pregnancy Outcomes in the Treatment of Booking Gestational Diabetes Mellitus Study.
    Diabetes Care. 2024 Mar 29:dc232215. doi: 10.2337/dc23-2215.
    

    >> Share

    
    

    
    Diabetes Obes Metab

27. GOLUBIC R, Kennet J, Parker V, Robertson D, et al
    Dual glucagon-like peptide-1 and glucagon receptor agonism reduces energy intake in type 2 diabetes with obesity.
    Diabetes Obes Metab. 2024 Apr 1. doi: 10.1111/dom.15579.
    

    >> Share

    
    
28. VIVIAN EM, Chewning BA, Voils CI, Brown RL, et al
    Healthy Outcomes through Peer Educators: Feasibility of a peer support diabetes prevention programme for African-American grandmother caregivers.
    Diabetes Obes Metab. 2024 Apr 3. doi: 10.1111/dom.15574.
    

    >> Share

    
    
29. LUO J, Zhao X, Li Q, Zou B, et al
    Evaluating the global impact of low physical activity on type 2 diabetes: Insights from the global burden of disease 2019 study.
    Diabetes Obes Metab. 2024 Apr 1. doi: 10.1111/dom.15568.
    

    >> Share

    
    
30. SAFDAR NZ, Alobaid AM, Hopkins M, Dempsey PC, et al
    Short, frequent, light-intensity walking activity improves postprandial vascular-inflammatory biomarkers in people with type 1 diabetes: The SIT-LESS randomized controlled trial.
    Diabetes Obes Metab. 2024 Apr 1. doi: 10.1111/dom.15564.
    

    >> Share

    
    
31. KUHNE T, Wallace E, Herzig D, Helleputte S, et al
    Combined intake of caffeine and low-dose glucose to reduce exercise-related hypoglycaemia in individuals with type 1 diabetes on ultra-long-acting insulin degludec: A randomized, controlled, double-blind, cross-over trial.
    Diabetes Obes Metab. 2024 Apr 1. doi: 10.1111/dom.15580.
    

    >> Share

    
    
32. DARSALIA V, Vercalsteren E, Karampatsi D, Romanitan MO, et al
    The need for registry-based studies in diabetes and stroke: A unique opportunity to understand whether diabetic treatments improve post-stroke outcome.
    Diabetes Obes Metab. 2024 Apr 1. doi: 10.1111/dom.15577.
    

    >> Share

    
    
33. CHRISTOFIDES EA, Puente O, Norwood P, Denham D, et al
    Immunogenicity, efficacy, and safety of biosimilar insulin glargine (Gan & Lee glargine) compared with originator insulin glargine (Lantus(R)) in patients with type 2 diabetes after 26 weeks' treatment: A randomized open label study.
    Diabetes Obes Metab. 2024 Apr 1. doi: 10.1111/dom.15560.
    

    >> Share

    
    
34. HUANG ZG, Gao JW, Zhang HF, You S, et al
    Cardiovascular health metrics defined by Life's Essential 8 scores and subsequent macrovascular and microvascular complications in individuals with type 2 diabetes: A prospective cohort study.
    Diabetes Obes Metab. 2024 Apr 1. doi: 10.1111/dom.15583.
    

    >> Share

    
    
35. TALHA KM, Green J, Filippatos G, Pocock S, et al
    Impact of empagliflozin on insulin needs in patients with heart failure and diabetes: An EMPEROR-Pooled analysis.
    Diabetes Obes Metab. 2024 Apr 1. doi: 10.1111/dom.15572.
    

    >> Share

    
    
36. MAHMOUD F, Mueller T, Mullen A, Sainsbury C, et al
    Patterns of initial and first-intensifying antidiabetic drug utilization among patients with type 2 diabetes mellitus in Scotland, 2010-2020: A retrospective population-based cohort study.
    Diabetes Obes Metab. 2024 Apr 1. doi: 10.1111/dom.15584.
    

    >> Share

    
    
37. ANSON M, Henney AE, Zhao SS, Ibarburu GH, et al
    Effect of combination pioglitazone with sodium-glucose cotransporter-2 inhibitors or glucagon-like peptide-1 receptor agonists on outcomes in type 2 diabetes: A systematic review, meta-analysis, and real-world study from an international federated dat
    Diabetes Obes Metab. 2024 Apr 1. doi: 10.1111/dom.15576.
    

    >> Share

    
    
38. KANBAY M, Copur S, Topcu AU, Guldan M, et al
    An update review of post-transplant diabetes mellitus: Concept, risk factors, clinical implications and management.
    Diabetes Obes Metab. 2024 Apr 1. doi: 10.1111/dom.15575.
    

    >> Share

    
    
39. HODGSON A, Gillies CL, Highton P, Haddon L, et al
    Risk of lower extremity amputation in patients with type 2 diabetes mellitus and peripheral arterial disease receiving sodium-glucose cotransporter-2 inhibitors versus other medications: A systematic review and meta-analysis of observational cohort st
    Diabetes Obes Metab. 2024 Apr 1. doi: 10.1111/dom.15571.
    

    >> Share

    
    

    
    Diabetologia

40. XIE C, Iroga P, Bound MJ, Grivell J, et al
    Impact of the timing of metformin administration on glycaemic and glucagon-like peptide-1 responses to intraduodenal glucose infusion in type 2 diabetes: a double-blind, randomised, placebo-controlled, crossover study.
    Diabetologia. 2024 Apr 1. doi: 10.1007/s00125-024-06131.
    

    >> Share

    
    
41. SIERRA-SILVESTRE E, Andrade RJ, Colorado LH, Edwards K, et al
    Correction to: Occurrence of corneal sub-epithelial microneuromas and axonal swelling in people with diabetes with and without (painful) diabetic neuropathy.
    Diabetologia. 2024 Apr 5. doi: 10.1007/s00125-024-06138.
    

    >> Share

    
    

    
    Eur J Endocrinol

42. ATILA C, Beck J, Refardt J, Erlic Z, et al
    Psychopathological characteristics in patients with arginine vasopressin deficiency (central diabetes insipidus) and primary polydipsia compared to healthy controls.
    Eur J Endocrinol. 2024 Mar 29:lvae040. doi: 10.1093.
    

    >> Share

    
    

    
    J Am Coll Cardiol

43. COSTANZO MR, Januzzi JL
    Early SGLT2 Inhibitors in Acute Heart Failure: Safe Diuretic-Sparing Strategy.
    J Am Coll Cardiol. 2024;83:1307-1309.
    

    >> Share

    
    

    
    J Am Soc Nephrol

44. FWU CW, Eggers PW, Norton JM, Gipson DS, et al
    Age- and Race-Specific Changes in End Stage Kidney Disease Incidence over Four Decades.
    J Am Soc Nephrol. 2024 Jan 30. doi: 10.1681/ASN.0000000000000310.
    

    >> Share

    
    
45. ISAKSSON GL, Hinrichs GR, Andersen H, Bach ML, et al
    Amiloride Reduces Urokinase/Plasminogen-Driven Intratubular Complement Activation in Glomerular Proteinuria.
    J Am Soc Nephrol. 2024;35:410-425.
    

    >> Share

    
    

    
    J Biol Chem

46. LI L, Yao Y, Wang Y, Cao J, et al
    G protein-coupled estrogen receptor 1 ameliorates nonalcoholic steatohepatitis through targeting AMPK-dependent signaling.
    J Biol Chem. 2024;300:105661.
    

    >> Share

    
    

    
    J Clin Endocrinol Metab

47. SAEI GHARE NAZ M, Farhadi-Azar M, Noroozzadeh M, Farahmand M, et al
    Follicle-Stimulating Hormone and Diabetes in Postmenopausal Women: A Systematic Review and Meta-analysis.
    J Clin Endocrinol Metab. 2024 Mar 30:dgae198. doi: 10.1210.
    

    >> Share

    
    
48. PUDDU PE, Menotti A
    Diabetes duration and the reverse impact between cholesterol levels and risk among individuals with type 2 diabetes.
    J Clin Endocrinol Metab. 2024 Apr 3:dgae217. doi: 10.1210.
    

    >> Share

    
    
49. WEN H, Niu X, Yu R, Zhao R, et al
    Association of Serum AGR With All-Cause and Cause-Specific Mortality Among Individuals With Diabetes.
    J Clin Endocrinol Metab. 2024 Apr 4:dgae215. doi: 10.1210.
    

    >> Share

    
    
50. FU Y, Lu M, Zhang K, Sun Y, et al
    Vitamin D status, vitamin D receptor polymorphisms, and risk of type 2 diabetes: A prospective cohort study.
    J Clin Endocrinol Metab. 2024 Apr 4:dgae221. doi: 10.1210.
    

    >> Share

    
    

    
    J Diabetes Complications

51. RAKOTOARISOA L, Weiss L, Lefebvre F, Porzio M, et al
    Early glucose abnormalities revealed by continuous glucose monitoring associate with lung function decline in cystic fibrosis: A five-year prospective study.
    J Diabetes Complications. 2024;38:108703.
    

    >> Share

    
    
52. LASSCHUIT JWJ, Center JR, Greenfield JR, Tonks KTT, et al
    Effect of denosumab on inflammation and bone health in active Charcot foot: A phase II randomised controlled trial.
    J Diabetes Complications. 2024;38:108718.
    

    >> Share

    
    
53. FONSECA LM, Kanapka L, Miller K, Pratley R, et al
    Risk factors associated with cognitive performance and cognitive impairment in older adults with type 1 diabetes: Data from the Wireless Innovation for Seniors with Diabetes Mellitus (WISDM) study.
    J Diabetes Complications. 2024;38:108739.
    

    >> Share

    
    
54. FILARDI T, Feraco A, Ouvrard-Pascaud A, Rizzo M, et al
    Managing cardio-renal-metabolic risk in patients with type 2 diabetes: the role of finerenone.
    J Diabetes Complications. 2024;38:108741.
    

    >> Share

    
    
55. VUORLAAKSO M, Karen V, Kiiski J, Lahtela J, et al
    Multidisciplinary management of diabetic foot infection associated with improved 8-year overall survival.
    J Diabetes Complications. 2024;38:108719.
    

    >> Share

    
    

    
    JAMA

56. BOGGESS KA
    Metformin Plus Insulin for Preexisting Diabetes or Gestational Diabetes in Pregnancy-Reply.
    JAMA. 2024 Apr 3. doi: 10.1001/jama.2024.1383.
    

    >> Share

    
    
57. POURKARIM F, Entezari-Maleki T
    Metformin Plus Insulin for Preexisting Diabetes or Gestational Diabetes in Pregnancy.
    JAMA. 2024 Apr 3. doi: 10.1001/jama.2024.1380.
    

    >> Share

    
    
58. FANG M, Wang D, Selvin E
    Prevalence of Type 1 Diabetes Among US Children and Adults by Age, Sex, Race, and Ethnicity.
    JAMA. 2024 Apr 4. doi: 10.1001/jama.2024.2103.
    

    >> Share

    
    
59. HARRIS E
    Less Sleep Tied to Increased Risk of Diabetes Despite Healthy Diet.
    JAMA. 2024 Apr 5. doi: 10.1001/jama.2024.4498.
    

    >> Share

    
    

    
    Nat Genet

60. ZHAO Y, Chukanova M, Kentistou KA, Fairhurst-Hunter Z, et al
    Protein-truncating variants in BSN are associated with severe adult-onset obesity, type 2 diabetes and fatty liver disease.
    Nat Genet. 2024 Apr 4. doi: 10.1038/s41588-024-01694.
    

    >> Share

    
    

    
    Nature

61. ADAM D
    Diabetes drug slows development of Parkinson's disease.
    Nature. 2024 Apr 3. doi: 10.1038/d41586-024-00974.
    

    >> Share

    
    

    
    Nutr Metab (Lond)

62. LI X, Xue Y, Zhang Y, Wang Q, et al
    Association between dietary antioxidant capacity and type 2 diabetes mellitus in Chinese adults: a population-based cross-sectional study.
    Nutr Metab (Lond). 2024;21:16.
    

    >> Share

    
    

    
    Pediatr Rev

63. GRANADOS A, Carrillo Iregui A
    Type 1 Diabetes Management in the Hospital Setting.
    Pediatr Rev. 2024;45:201-209.
    

    >> Share

    
    

    
    PLoS One

64. TAN MHP, Ong SC, Tahir NAM, Ali AM, et al
    Health state utility values ranges across varying stages and severity of type 2 diabetes-related complications: A systematic review.
    PLoS One. 2024;19:e0297589.
    

    >> Share

    
    
65. ABONIE US, Addo RA, Kumah L, Ofori-Ampomah AK, et al
    Effect of treadmill ambulatory training on glucose control and blood pressure in persons with type 2 diabetes: A pilot study.
    PLoS One. 2024;19:e0298179.
    

    >> Share

    
    
66. MEDINA-RAMIREZ SA, Soriano-Moreno DR, Tuco KG, Castro-Diaz SD, et al
    Prevalence and incidence of diabetic retinopathy in patients with diabetes of Latin America and the Caribbean: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0296998.
    

    >> Share

    
    
67. STAUFFER WT, Bobardt M, Ure DR, Foster RT, et al
    Cyclophilin D knockout significantly prevents HCC development in a streptozotocin-induced mouse model of diabetes-linked NASH.
    PLoS One. 2024;19:e0301711.
    

    >> Share

    
    
68. YU F, Pituch KA, Maxfield M, Baena E, et al
    The associations between type 2 diabetes and plasma biomarkers of Alzheimer's disease in the Health and Aging Brain Study: Health Disparities (HABS-HD).
    PLoS One. 2024;19:e0295749.
    

    >> Share

    
    
69. TILHOU AS, Dague L, Chachlani P, Burns M, et al
    Can telehealth expansion boost health care utilization specifically for patients with substance use disorders relative to patients with other types of chronic disease?
    PLoS One. 2024;19:e0299397.
    

    >> Share

    
    
70. MA J, Gao R, Xie Q, Pan X, et al
    Whole transcriptome sequencing analyses of islets reveal ncRNA regulatory networks underlying impaired insulin secretion and increased beta-cell mass in high fat diet-induced diabetes mellitus.
    PLoS One. 2024;19:e0300965.
    

    >> Share

    
    
71. ASHOOBI MT, Hemmati H, Moayerifar M, Moayerifar M, et al
    The role of diabetic foot treatment in improving left ventricular function: Insights from global longitudinal strain echocardiography.
    PLoS One. 2024;19:e0299887.
    

    >> Share

    
    
72. DAMIRI B, Abumohsen H, BelKebir S, Hamdan M, et al
    The epidemiology of gestational diabetes, gestation hypertension, and anemia in North Palestine from 2018 to 2020: A retrospective study.
    PLoS One. 2024;19:e0301145.
    

    >> Share

    
    
73. MADEDE T, Mavume Mangunyane E, Munguambe K, Govo V, et al
    Human resources challenges in the management of diabetes and hypertension in Mozambique.
    PLoS One. 2024;19:e0297676.
    

    >> Share

    
    
74. NIEDERMAYER F, Schauberger G, Rathmann W, Klug SJ, et al
    Clusters of longitudinal risk profile trajectories are associated with cardiometabolic diseases: Results from the population-based KORA cohort.
    PLoS One. 2024;19:e0300966.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share